References
1a
Harada T.
Katsuhira T.
Hattori K.
Oku A.
J. Org. Chem.
1993,
58:
2958
1b
The Chemistry of the Cyclopropyl Group
Patai S.
Rappoport Z.
Wiley;
New York:
1987.
1c
Hoveyda AH.
Evans DA.
Fu GC.
Chem. Rev.
1993,
93:
1370
1d
Doyle MP.
Forbes DC.
Chem. Rev.
1998,
98:
911
1e
Li AH.
Dai LX.
Aggarwal VK.
Chem. Rev.
1997,
97:
2341
1f
Suzuki ND.
Kondakov Y.
Kageyama M.
Kotora M.
Hara R.
Takahashi T.
Tetrahedron
1995,
51:
4519
2
Yachi K.
Shinokubo H.
Oshima K.
Angew. Chem. Int. Ed.
1998,
37:
2515
3
Chen H.
Deng M.-Z.
J. Org. Chem.
2000,
65:
4444
4a
Wakefield BJ.
Organolithium Method
Academic Press;
London:
1988.
4b
Wakefield BJ.
Organomagnesium Methods in Organic Synthesis
Academic Press;
London:
1995.
For the preparation of cyclopropylmetal compounds by carbometalation of cyclopropene, see:
5a
Stoll AT.
Negishi E.
Tetrahedron Lett.
1985,
26:
5671
5b
Nakamura E.
Isaka M.
Matsuzawa S.
J. Am. Chem. Soc.
1988,
110:
1297
5c
Isaka M.
Nakamura E.
J. Am. Chem. Soc.
1990,
112:
7428
5d
Isaka M.
Ejiri S.
Nakamura E.
Tetrahedron
1992,
48:
2047
6a Boron: Imai T.
Mineta H.
Nishida S.
J. Org. Chem.
1990,
55:
4986
6b
Fontani P.
Carboni B.
Vaultier M.
Mass G.
Synthesis
1991,
605
6c
Wang X.-Z.
Deng M.-Z.
J. Chem. Soc., Perkin. Trans. 1
1996,
2663
6d
Hildebrand JP.
Marsden SP.
Synlett
1996,
893
6e
Pietruszka J.
Widenmeyer M.
Synlett
1997,
977
6f Aluminum: Zweifel G.
Clark GM.
Whitney CC.
J. Am. Chem. Soc.
1971,
93:
1305
6g Silicon: Hirabayashi K.
Mori A.
Hiyama T.
Tetrahedron Lett.
1997,
38:
461
6h Zinc: see references 1a,2.
7
Dulayymi JRA.
Baird MS.
Boiesov IG.
Tveresovsky V.
Rubin M.
Tetrahedron Lett.
1996,
38:
461
8a
Jung ME.
Light LA.
Tetrahedron Lett.
1982,
23:
3861
8b
Shinokubo H.
Miki H.
Yokoo K.
Utimoto K.
Tetrahedron
1995,
51:
11681
9a
Kubota K.
Nakamura M.
Nakamura E.
J. Am. Chem. Soc.
1993,
115:
5867
9b
Nakamura M.
Arai M.
Nakamura E.
J. Am. Chem. Soc.
1995,
117:
1179
9c
Kubota K.
Mori S.
Nakamura M.
Nakamura E.
J. Am. Chem. Soc.
1998,
120:
13334
9d
Nakamura M.
Hirai A.
Nakamura E.
J. Am. Chem. Soc.
2000,
122:
978
9e
Nakamura M.
Inoue T.
Sato A.
Nakamura E.
Org. Lett.
2000,
2:
2193
9f
Nakamura M.
Inoue T.
Nakamura E.
J. Organomet. Chem.
2001,
624:
300
9g
Nakamura M.
Isobe H.
Nakamura E.
Chem. Rev.
2003,
103:
1295
10a
Araki S.
Nakano H.
Subburaj K.
Hirashita T.
Shibutani K.
Yamamura H.
Kawai M.
Butsugan Y.
Tetrahedron Lett.
1998,
39:
6327
10b
Richey HG.
Bension RM.
J. Org. Chem.
1980,
45:
5036
10c
Nesmeyanova OA.
Rudashevskaya TY.
Dyachenka AI.
Savitova SF.
Nefedov OM.
Synthesis
1982,
296
11a
Chen C.
Xi C.
Jiang Y.
Hong X.
Tetrahedron Lett.
2004,
45:
6067
11b
Xi C.
Chen C.
Lin J.
Hong X.
Org. Lett.
2005,
7:
347
12 Conjugate addition is often used in the formation of cyclic compound, see: Perlmutter P.
Conjugate Addition Reactions in Organic Synthesis, In Tetrahedron Organic Chemistry Series 9
Pergamon Press;
Oxford:
1992.
13
Sato F.
Ishikawa H.
Sato M.
Tetrahedron Lett.
1981,
22:
85
14a
Kawakami Y.
Tsuruta T.
Tetrahedron Lett.
1971,
12:
1173
14b
Tsuruta T.
Kawakawi Y.
Tetrahedron
1973,
29:
1173
15a
Takahashi T.
Aoyagi K.
Hara R.
Suzuki N.
J. Chem. Soc., Chem. Commun.
1993,
1042
15b
Takahashi T.
Aoyagi K.
Kondakov DY.
J. Chem. Soc., Chem. Commun.
1994,
747
16
Takahashi T.
Kageyama M.
Denisov N.
Negishi E.
Tetrahedron Lett.
1993,
34:
687
17
Typical Procedure for Allyl-Substituted Cyclopropanes. Preparation of 1-Bromo-2-(2-ethylpent-2-enyl)cyclo-propane-1,2-dicarboxylic Acid Dimethyl Ester (4a).
To a mixture of Cp2TiCl2 (0.05 mmol, 15 mg) and 3-hexyne (1.0 mmol, 115 µL) in Et2O (3.0 mL) was added i-BuMgBr (1.1 mmol, 1.0 M in Et2O) at -78 °C. Then the mixture was warmed to r.t. and stirred for 1 h. Before CuCl (0.1 mmol, 10 mg) and methyl 2-bromo-acrylate (2.0 mmol, 230 µL) were added, the mixture was cooled to -30 °C using ice-salt bath and maintained at the same temperature for 1 h. After an additional 1 h, the suspension was quenched with 3 N HCl and aqueous layers were extracted with 15 mL of Et2O for 3 times. The combined organic layers were dried over Na2SO4. The solvent was evaporated and the product was purified by column chromatography with petroleum ether-Et2O = 10:1 as elution to afford the title compound 4a as a colorless liquid (193 mg, 58% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 0.89-0.98 (m, 6 H), 1.40 (d, J = 6.5 Hz, 1 H), 1.95-2.05 (m, 4 H), 2.37 (d, J = 15.0 Hz, 1 H), 2.47 (d, J = 6.5 Hz, 1 H), 2.87 (d, J = 15.0 Hz, 1 H), 3.63 (s, 3 H), 3.74 (s, 3 H), 5.22 (t, J = 7.2 Hz, 1 H). 13C NMR (SiMe4, CDCl3): δ = 13.02, 14.47, 20.76, 22.95, 27.41, 36.83, 37.46, 40.26, 52.28, 53.45, 128.94, 136.17, 168.05, 169.67. HRMS: m/z calcd for C14H21BrO4: 332.0623, 334.0603; found: 332.0628, 334.0610.
18
1-Bromo-2-(2-butylhept-2-enyl)cyclopropane-1,2-dicarboxylic Acid Dimethyl Ester (4b).
Colorless liquid (237 mg, 61% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 0.81-0.88 (m, 6 H), 1.15-1.27 (m, 9 H), 1.90-1.96 (m, 4 H), 2.30-2.37 (m, 2 H), 2.77 (d, J = 15.0 Hz, 1 H), 3.54 (s, 3 H), 3.65 (s, 3 H), 5.18 (t, J = 7.2 Hz, 1 H). 13C NMR (SiMe4, CDCl3): δ = 13.70, 13.74, 21.95, 22.39, 27.06, 27.13, 29.51, 30.17, 31.81, 36.37, 37.29, 40.34, 51.98, 53.10, 127.48, 134.85, 167.67, 169.39. HRMS: m/z calcd for C18H29BrO4: 388.1249, 390.1229; found: 388.1251, 390.1233.
19
Typical Procedure for the Reaction of Zirconacyclo-pentene with 2-Bromo-acrylate. Preparation of 1-Bromo-2-(3-ethyl-2-propylhex-2-enyl)cyclopropane-1,2-dicarboxylic Acid Dimethyl Ester (4c).
To a solution of Cp2ZrCl2 (1.2 mmol, 0.352 g) in THF (5.0 mL) was added EtMgBr (0.89 M in Et2O, 2.40 mmol) at -78 °C and the mixture was stirred for 1 h. After addition of 4-octyne (1.0 mmol, 144 µL) the mixture was warmed up to 0 °C and stirred for 1 h. Before CuCl (1.0 mmol, 99 mg) and methyl 2-bromo-acrylate (2.0 mmol, 230 mL) were added, the mixture was cooled to -30 °C using ice-salt bath and maintained at the temperature for 1 h. The suspension was quenched with 3 N HCl and aqueous layers were extracted with Et2O (3 × 15 mL). The combined organic layers were dried over Na2SO4. The solvent was evaporated and the product was purified by column chromatography with petroleum ether-Et2O = 10:1 as eluent to afford 4c as a colorless liquid (245 mg, 63%). 1H NMR (SiMe4, CDCl3): δ = 0.86-0.91 (m, 9 H), 1.28-1.37 (m, 6 H), 1.39 (d, J = 7.0 Hz, 1 H), 1.87 (q, J = 7.0 Hz, 2 H), 2.00-2.07 (m, 3 H), 2.19 (q, J = 7.5 Hz, 2 H), 2.48 (d, J = 6.5 Hz, 1 H), 3.17 (d, J = 14.5 Hz, 1 H), 3.57 (s, 3 H), 3.72 (s, 3 H). 13C NMR (SiMe4, CDCl3): δ = 13.65, 14.08, 14.33, 21.89, 22.29, 24.50, 28.72, 32.06, 33.52, 35.17, 36.93, 38.61, 52.15, 53.62, 128.18, 139.73, 168.41, 169.27. HRMS: m/z calcd for C18H29BrO4: 388.1249, 390.1229; found: 388.1268, 390.1235.
20
1-Bromo-2-(2,3-diethylpent-2-enyl)cyclopropane-1,2-dicarboxylic Acid Dimethyl Ester (4d).
Colorless liquid (125 mg, 69% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 0.91-0.94 (m, 9 H), 1.42 (d, J = 6.5 Hz, 1 H), 1.92 (q, J = 7.5 Hz, 2 H), 2.02-2.12 (m, 3 H), 2.20 (q, J = 7.5 Hz, 2 H), 2.49 (d, J = 6.0 Hz, 1 H), 3.17 (d, J = 14.0 Hz, 1 H), 3.58 (s, 3 H), 3.73 (s, 3 H). 13C NMR (SiMe4, CDCl3): δ = 13.42, 13.53, 13.68, 22.97, 24.07 (2 C), 28.73, 34.91, 36.94, 38.63, 53.13, 53.63, 129.30, 140.56, 168.46, 169.31. HRMS: m/z calcd for C16H25BrO4: 360.0936, 362.0916; found: 360.0940, 362.0923.
21
1-Bromo-2-[3-(2-d-ethyl)-2-propylhex-2-enyl]cyclo-propane-1,2-dicarboxylic Acid Dimethyl Ester (5).
Colorless liquid (127 mg, 70% isolated yield) 1H NMR (SiMe4, CDCl3): δ = 0.87-0.91 (m, 8 H), 1.28-1.37 (m, 6 H), 1.39 (d, J = 7.0 Hz, 1 H), 1.87 (q, J = 7.0 Hz, 2 H), 2.00-2.07 (m, 3 H), 2.19 (q, J = 7.5 Hz, 2 H), 2.48 (d, J = 6.5 Hz, 1 H), 3.17 (d, J = 14.5 Hz, 1 H), 3.57 (s, 3 H), 3.72 (s, 3 H). 13C NMR (SiMe4, CDCl3): δ = 13.37 (t), 14.08, 14.33, 21.89, 22.29, 24.50, 28.72, 32.06, 33.52, 35.17, 36.93, 38.61, 52.15, 53.62, 128.18, 139.73, 168.41, 169.27. HRMS: m/z calcd for C18H28DBrO4: 389.1311, 391.1290; found: 389.1316, 391.1293.
22
1-Bromo-2-(2-phenylpent-2-enyl)cyclopropane-1,2-dicarboxylic Acid Dimethyl Ester (4e).
Colorless liquid (284 mg, 72% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 1.04 (t, J = 7.5 Hz, 3 H), 2.14-2.24 (m, 3 H), 2.73 (d, J = 14.4 Hz, 1 H), 3.44 (s, 3 H), 3.67 (s, 3 H), 5.60 (t, J = 7.2 Hz, 3 H), 7.20-7.28 (m, 5 H). 13C NMR (SiMe4, CDCl3): δ = 14.41, 22.10, 27.89, 34.69, 38.04, 52.29, 53.67, 126.97, 127.39, 128.18, 135.05, 135.91, 143.14, 168.15, 169.22. HRMS: m/z calcd for C18H21BrO4, 380.0623, 382.0603; found: 380.0621, 382.0605.
23
1-Bromo-2-(2,3-diphenylpent-2-enyl)cyclopropane-1,2-dicarboxylic Acid Dimethyl Ester (4f).
Colorless liquid (204 mg, 45% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 0.94 (t, J = 7.0 Hz, 3 H), 1.20 (q, J = 7.0 Hz, 2 H), 1.84 (d, J = 3.5 Hz, 1 H), 2.06 (d, J = 7.0 Hz, 1 H), 2.45 (d, J = 7.0 Hz, 1 H), 2.71 (d, J = 14.0 Hz, 1 H), 3.57 (s, 3 H), 3.67 (s, 3 H), 6.87-6.91 (m, 4 H), 6.97-6.99 (m, 2 H), 7.01-7.05 (m, 4 H). 13C NMR (SiMe4, CDCl3,): δ = 13.01, 27.39, 27.61, 37.22, 37.42, 38.35, 52.10, 53.49, 125.78, 125.95, 127.44 (2 C), 129.54, 130.04, 133.00, 141.82, 142.34, 143.53, 168.09, 169.33. HRMS: m/z calcd for C24H25BrO4: 456.0936, 458.0916; found: 456.0940, 458.0918.
24
1-Bromo-2-(3-methyl-2-phenylpent-2-enyl)cyclo-propane-1,2-dicarboxylic Acid Dimethyl Ester (4g).
Colorless liquid (284 mg, 72% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 0.88 (s, 3 H), 1.06 (t, J = 7.5 Hz, 3 H), 1.40 (q, J = 6.5 Hz, 2 H), 1.59 (d, J = 4.0 Hz, 1 H), 2.08 (d, J = 3.5 Hz, 1 H), 2.37 (d, J = 3.5 Hz, 1 H), 2.47 (d, J = 14.5 Hz, 1 H), 3.57 (s, 3 H), 3.68 (s, 3 H), 7.06-7.08 (m, 2 H), 7.20-7.21 (m, 1 H), 7.22-7.30 (m, 2 H). 13C NMR (SiMe4, CDCl3,): δ = 13.06, 19.36, 26.72, 27.45, 37.29, 38.13, 38.30, 52.24, 53.48, 126.28, 128.00, 129.34, 136.93, 142.67, 168.15, 169.46. HRMS: m/z calcd for C19H23BrO4: 394.0780, 396.0759; found: 394.0798, 396.0782.
25
1-Bromo-2-(2-naphthalen-1-ylpent-2-enyl)cyclo-propane-1,2-dicarboxylic Acid Dimethyl Ester (4h).
Colorless liquid (223 mg, 52% isolated yield). 1H NMR (SiMe4, CDCl3): δ = 1.12 (t, J = 7.5 Hz, 3 H), 2.03 (d, J = 6.9 Hz, 1 H), 2.39 (m, 2 H), 2.78 (d, J = 6.9 Hz, 1 H), 3.66 (s, 3 H), 3.76 (s, 3 H), 5.63 (t, J = 7.2 Hz, 3 H), 7.38-7.92 (m, 7 H). 13C NMR (SiMe4, CDCl3): δ = 14.52, 21.76, 36.31, 36.44, 52.33, 53.54, 125.33, 125.59, 125.70, 125.89, 127.36, 128.41, 133.73, 134.20, 136.57, 141.00, 167.92, 169.53. HRMS: m/z calcd for C22H23BrO4: 430.0780, 432.0759; found: 430.0766, 432.0743.
26
trans
-1-Chloro-2-(2,3-diethylpent-2-enyl)cyclopropane-1,2-dicarbonitrile (
4i).
1H NMR (SiMe4, CDCl3): δ = 0.98-1.06 (m, 9 H), 1.94 (d, J = 7.5 Hz, 1 H), 2.05-2.19 (m, 7 H), 2.38 (d, J = 15.0 Hz, 1 H), 2.81 (d, J = 15.0 Hz, 1 H). 13C NMR (SiMe4, CDCl3): δ = 13.48, 13.49, 13.58, 23.91, 24.23, 24.73, 27.58, 30.07, 31.33, 33.35, 114.86, 116.00, 126.72, 143.66. HRMS:
m/z calcd for C14H19ClN2: 250.1237, 252.1207; found: 250.1242, 252.1225.
27
cis
-1-Chloro-2-(2,3-diethylpent-2-enyl)cyclopropane-1,2-dicarbonitrile (3i).
1H NMR (SiMe4, CDCl3): δ = 0.94-1.05 (m, 9 H), 1.67 (d, J = 7.5 Hz, 1 H), 2.08-2.17 (m, 7 H), 2.32 (d, J = 15.0 Hz, 1 H), 2.35 (d, J = 7.5 Hz, 1 H), 2.81 (d, J = 15.0 Hz, 1 H). 13C NMR (SiMe4, CDCl3): δ = 13.36, 13.41, 13.47, 23.65, 24.12, 24.62, 25.18, 29.59, 31.05, 33.29, 115.36, 116.81, 126.56, 143.48. HRMS: m/z calcd for C14H19ClN2: 250.1237, 252.1207; found: 250.1242, 252.1225.